The FDA appears to be open to considering Moderna's flu vaccine ahead of an upcoming advisory committee meeting. This development could signal a positive trajectory for the vaccine's approval process.
In other news, UniQure is set to submit its therapy for Huntington's disease for regulatory approval, marking a significant step in the treatment of this condition.
Additionally, Eli Lilly has made headlines with its acquisition of 4E Therapeutics, further expanding its portfolio in the biotech sector.